GenericDrugs

The Generic Drug Wars: TrumpRx Enters a Crowded Arena

The Prescription Price War Just Got a New Challenger

The Great Generic Drug Revolution: Mark Cuban, 'TrumpRx,' and the Fight for Affordable Medicine

The Prescription Price Revolution: New Players Shake Up Generic Drug Market

Healthcare on Wheels: Delhi Launches Mobile Jan Aushadi Kendras for Underserved Communities

Ivermectin's Unfulfilled Promise: A Potential Cancer Drug Quashed

The Hidden Cost of Healing: Unmasking the MRP Maze in Indian Healthcare

Navigating the Storm: Why US Tariffs Might Barely Dent India's Pharma Export Prowess

The Next Big Leap: Indian Pharma's Race for the Semaglutide Jackpot

A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope

Jharkhand's Ambitious Leap: Building a Pharmaceutical Powerhouse

India-EFTA Trade Deal Sparks Outcry: Farmers' Body Alleges 'Surrender' to US Corporates

The 'Skinny Label' Showdown: How a Supreme Court Case Could Redefine Generics and Drug Prices

A Landmark Win for Innovation: Delhi High Court Upholds Novo Nordisk's Semaglutide Patent

The Delhi High Court's Landmark Ruling on Semaglutide: A Win for Accessibility

A New Chapter for Multiple Sclerosis Treatment: Lupin's Landmark USFDA Approval

Major Win: Delhi High Court Greenlights Dr. Reddy's for Export-Only Weight-Loss Drug Production

Rethinking Drug Costs: Why Quick Fixes Might Hurt More Than Help

The Promise Unfulfilled: How Red Tape and Patents Block Access to a Game-Changing HIV Prevention Tool

Unlocking Access: The Global Battle for Affordable Medicines

Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

The Price of Pills: Can Trump's Battle for Cheaper Drugs Actually Reshape India's Pharma Future?

The Quiet Revolution: How Federal Officials Are Fighting for Cheaper Biotech Drugs

A Landmark Clash: India's Supreme Court Navigates Life-Saving SMA Drugs, Patents, and Public Access

President Trump's Landmark Initiative to Tackle Skyrocketing Prescription Drug Costs

Gilead Secures Extended Runway for Blockbuster HIV Drug After Landmark Patent Settlements

A Breath of Relief: How Trump's Drug Tariffs Spare India's Generic Pharma Giants

Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis

Trump's Bold Move: 100% Tariff on Branded Drugs Set to Shake Global Pharma, What It Means for India

India's Pharmaceutical Powerhouse Under Siege: Navigating Trump's Tariff Tempest

Trump's Tariff Twist: Generics Spared, But India's Export Horizon Remains Cloudy

Trump's Looming 100% Pharma Tariff: A Catastrophic Blow for India's Global Pharmacy?

A Game-Changer in HIV Treatment: Generic Drug Promises Unprecedented Affordability

The Enduring Saga of Drug Prices: Trump's Lingering Shadow on Healthcare Affordability

Lupin's Latest Triumph: US FDA Greenlight for HIV Drug Ignites Stock Rally

Trump's Rx for Disaster: Why a Paracetamol Ban Is a Perilous Prescription

India Delivers Major Blow to Novartis: Blockbuster Heart Drug Entresto Patent Revoked

Revolutionizing Healthcare: Government Unlocks Wider Access to Affordable Medicines with Bold New Policy